open access

Vol 49, No 2 (2017)
Original and clinical articles
Published online: 2017-05-18
Submitted: 2016-12-02
Accepted: 2017-04-12
Get Citation

Relationship between toll-like receptor 2 R753Q and T16934A polymorphisms and Staphylococcus aureus nasal carriage

Maciej Żukowski, Olga Taryma-Leśniak, Mariusz Kaczmarczyk, Katarzyna Kotfis, Łukasz Szydłowski, Andrzej Ciechanowicz, Mirosław Brykczyński, Agnieszka Żukowska
DOI: 10.5603/AIT.a2017.0027
·
Pubmed: 28518213
·
Anaesthesiol Intensive Ther 2017;49(2):110-115.

open access

Vol 49, No 2 (2017)
Original and clinical articles
Published online: 2017-05-18
Submitted: 2016-12-02
Accepted: 2017-04-12

Abstract

BACKGROUND: The association among specific single-nucleotide polymorphisms (SNPs) in TLR2 R753Q (rs5743708) and T16934A (rs4696480) and the nasal carriage of Staphylococcus aureus was studied in adults before CABG.

METHODS: The TLR2 polymorphisms were genotyped in 299 consecutive patients prepared for a CABG operation. Genotyping was performed using restriction fragment length polymorphism (RFLP) analysis of PCR-amplified fragments. Two nasal swab cultures were taken within 2 weeks before the operation. Subjects were classified as Staphylococcus aureus carriers if at least one culture was positive while those patients with both cultures found to be negative were classified as non-carriers.

RESULTS: The prevalence of nasal S. aureus carriage in the final cohort was 22.1% (66/299), while no MRSA was detected in our study group. No significant differences in the TLR2 polymorphisms were observed between the study and the control groups. No associations were found between TLR2 haplotypes and the covariates of age, sex, NYHA, weight, height, BMI, CAD, smoking status and ESlog score. No differences were found between carriers and noncarriers regarding the allelic distribution of the TLR2 T-16934A SNP. Almost 93% of the patients who were screened for the presence of the TLR2 Arg753Gln (rs5743708) were GG wild type homozygous. Twenty one subjects from the study group (7.1%) were GA heterozygous, while no patient in either group was homozygous for the TLR2 Arg753Gln (rs5743708) mutation. TLR2 Arg753Gln genotyping showed that GA heterozygous patients were detected more frequently in the group of Staphylococcus aureus nasal carriers than in non-carrier adults.

CONCLUSION: Our results suggest that the carrier status for the GA variant of the TLR2 Arg753Gln (rs5743708) polymorphism may be a risk factor for Staphylococcus aureus carriage.

Abstract

BACKGROUND: The association among specific single-nucleotide polymorphisms (SNPs) in TLR2 R753Q (rs5743708) and T16934A (rs4696480) and the nasal carriage of Staphylococcus aureus was studied in adults before CABG.

METHODS: The TLR2 polymorphisms were genotyped in 299 consecutive patients prepared for a CABG operation. Genotyping was performed using restriction fragment length polymorphism (RFLP) analysis of PCR-amplified fragments. Two nasal swab cultures were taken within 2 weeks before the operation. Subjects were classified as Staphylococcus aureus carriers if at least one culture was positive while those patients with both cultures found to be negative were classified as non-carriers.

RESULTS: The prevalence of nasal S. aureus carriage in the final cohort was 22.1% (66/299), while no MRSA was detected in our study group. No significant differences in the TLR2 polymorphisms were observed between the study and the control groups. No associations were found between TLR2 haplotypes and the covariates of age, sex, NYHA, weight, height, BMI, CAD, smoking status and ESlog score. No differences were found between carriers and noncarriers regarding the allelic distribution of the TLR2 T-16934A SNP. Almost 93% of the patients who were screened for the presence of the TLR2 Arg753Gln (rs5743708) were GG wild type homozygous. Twenty one subjects from the study group (7.1%) were GA heterozygous, while no patient in either group was homozygous for the TLR2 Arg753Gln (rs5743708) mutation. TLR2 Arg753Gln genotyping showed that GA heterozygous patients were detected more frequently in the group of Staphylococcus aureus nasal carriers than in non-carrier adults.

CONCLUSION: Our results suggest that the carrier status for the GA variant of the TLR2 Arg753Gln (rs5743708) polymorphism may be a risk factor for Staphylococcus aureus carriage.

Get Citation

Keywords

TLR 2, polymorphism; Staphylococcus aureus, carriage; cardiac surgery

About this article
Title

Relationship between toll-like receptor 2 R753Q and T16934A polymorphisms and Staphylococcus aureus nasal carriage

Journal

Anaesthesiology Intensive Therapy

Issue

Vol 49, No 2 (2017)

Pages

110-115

Published online

2017-05-18

DOI

10.5603/AIT.a2017.0027

Pubmed

28518213

Bibliographic record

Anaesthesiol Intensive Ther 2017;49(2):110-115.

Keywords

TLR 2
polymorphism
Staphylococcus aureus
carriage
cardiac surgery

Authors

Maciej Żukowski
Olga Taryma-Leśniak
Mariusz Kaczmarczyk
Katarzyna Kotfis
Łukasz Szydłowski
Andrzej Ciechanowicz
Mirosław Brykczyński
Agnieszka Żukowska

References (30)
  1. Fowler VG. Jr, O’Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED: Clinical predictors of major infections after cardiac surgery. Circulation. 2005; 112(Suppl 9): I358–65.
  2. Kollef MH, Sharpless L, Vlasnik J, et al. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997; 112(3): 666–675.
  3. Toumpoulis IK, Anagnostopoulos CE, Toumpoulis SK, et al. Risk factors for sepsis and endocarditis and long-term survival following coronary artery bypass grafting. World J Surg. 2005; 29(5): 621–7; discussion 627.
  4. Berríos-Torres SI, Yi SH, Bratzler DW, et al. Activity of commonly used antimicrobial prophylaxis regimens against pathogens causing coronary artery bypass graft and arthroplasty surgical site infections in the United States, 2006-2009. Infect Control Hosp Epidemiol. 2014; 35(3): 231–239.
  5. Nouwen J, Boelens H, van Belkum A, et al. Human factor in Staphylococcus aureus nasal carriage. Infect Immun. 2004; 72(11): 6685–6688.
  6. Bustamante J, Tamayo E, Flórez S, et al. Toll like receptor 2 ARG753GLN polymorphisms are associated with an increased risk of infective endocarditis. Rev Esp Cardiol. . 2011; 64: 1056–1059.
  7. Karaca N, Ozturk G, Gerceker BT, et al. TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients. J Eur Acad Dermatol Venereol. 2013; 27(1): e85–e90.
  8. Salpietro C, Rigoli L, Miraglia Del Giudice M, et al. TLR2 and TLR4 gene polymorphisms and atopic dermatitis in Italian children: a multicenter study. Int J Immunopathol Pharmacol. 2011; 24(4 Suppl): 33–40.
  9. Brown RA, Gralewski JH, Eid AJ, et al. R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins. Transplantation. 2010; 89(7): 811–815.
  10. Brown RA, Gralewski JH, Razonable RR. The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus. Clin Infect Dis. 2009; 49(9): e96–e99.
  11. Eid AJ, Brown RA, Paya CV, et al. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation. 2007; 84(4): 511–516.
  12. Kijpittayarit S, Eid AJ, Brown RA, et al. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis. 2007; 44(10): 1315–1320.
  13. Lorenz E, Mira JP, Cornish KL, et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun. 2000; 68(11): 6398–6401.
  14. Nischalke HD, Berger C, Aldenhoff K, et al. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol. 2011; 55(5): 1010–1016.
  15. Jensen L, Yang L. Risk factors for postoperative pulmonary complications in coronary artery bypass graft surgery patients. Eur J Cardiovasc Nurs. 2007; 6(3): 241–246.
  16. Kanafani ZA, Arduino JM, Muhlbaier LH, et al. Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery. Infect Control Hosp Epidemiol. 2009; 30(3): 242–248.
  17. Gamblin J, Jefferies JM, Harris S, et al. Nasal self-swabbing for estimating the prevalence of Staphylococcus aureus in the community. J Med Microbiol. 2013; 62(Pt 3): 437–440.
  18. Abudu L, Blair I, Fraise A, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect. 2001; 126(3): 351–356.
  19. Lorenz E, Mira JP, Frees KL, et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med. 2002; 162(9): 1028–1032.
  20. Echchannaoui H, Frei K, Schnell C, et al. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis. 2002; 186(6): 798–806.
  21. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 2000; 165(10): 5392–5396.
  22. Kang TJ, Chae GT. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol. 2001; 31(1): 53–58.
  23. Osmon DR, Razonable RR. Functional assessment of toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis. . Hum Immunol. 2011; 72(1): 47–53.
  24. Reiling N, Holscher C, Fehrenbach A, et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4 mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol. . 2002(169): 3480–3484.
  25. Schröder NWJ, Diterich I, Zinke A, et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol. 2005; 175(4): 2534–2540.
  26. Liu H, Komai-Koma M, Xu D, et al. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A. 2006; 103(18): 7048–7053.
  27. Liu J, Rädler D, Illi S, et al. TLR2 polymorphisms influence neonatal regulatory T cells depending on maternal atopy. Allergy. 2011; 66(8): 1020–1029.
  28. Nischalke HD, Berger C, Aldenhoff K, et al. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol. 2011; 55(5): 1010–1016.
  29. Lee SO, Brown RA, Kang SH, et al. Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation. Liver Transpl. 2011; 17(9): 1081–1088.
  30. Kaczała M, Kopron K, Gmyrek J, et al. Kolonizacja (zakażenie) dróg oddechowych u chorych leczonych ambulatoryjnie w latach 2000-2005. Pol. Merk. Lek. , 2008, XXIV. ; 141: 195.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl